Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease

A A Hislop1, S G Haworth

  • 1Department of Paediatric Cardiology, Institute of Child Health, London, England.

Pediatric Pulmonology
|January 1, 1990
PubMed

Insights

Infants with chronic lung disease after hyaline membrane disease (HMD) show reduced alveoli and thickened pulmonary arteries, regardless of cor pulmonale (CP). Vascular changes persist even after recovery from HMD.

Area of Science:

  • Pediatric Pathology
  • Pulmonary Medicine
  • Neonatology

Background:

  • Hyaline membrane disease (HMD) is a common neonatal respiratory disorder.
  • Chronic lung disease (CLD) can develop in infants following HMD.
  • Pulmonary vascular remodeling is a known complication of neonatal lung injury.

Purpose of the Study:

  • To investigate pulmonary vascular morphology in infants and young children with CLD following HMD.
  • To determine the relationship between pulmonary vascular changes and the presence or absence of cor pulmonale (CP).
  • To assess if vascular abnormalities correlate with the severity of lung disease or recovery status.

Main Methods:

  • Light microscopic morphometric techniques were employed.
  • Lungs from 17 infants and young children (2 weeks to 3.5 years) with CLD post-HMD were studied.
  • Patients were categorized into three groups based on illness course and presence of CP.

Main Results:

  • All groups exhibited reduced alveolar counts and increased bronchial smooth muscle in small airways.
  • Pulmonary arterial medial thickness was significantly increased in all three groups (P < 0.001).
  • Vascular changes ranged from persistence of fetal state to marked secondary muscularity, with extension into smaller arteries in some groups.

Conclusions:

  • Infants recovering from HMD can have significant pulmonary vascular abnormalities even without cor pulmonale.
  • The presence of cor pulmonale does not necessarily indicate advanced obliterative pulmonary vascular disease.
  • Pulmonary vascular morphology does not consistently correlate with the presence or absence of cor pulmonale in this cohort.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...